歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01672 歌礼制药-B

已收盘 03-28 16:08:10

7.450

-0.070

-0.93%

最高7.720	最低6.780	成交量1,037万
今开7.500	昨收7.520	日振幅12.50%
总市值71.67亿	流通市值71.67亿	总股本9.62亿
成交额7,567万	换手率1.08%	流通股本9.62亿
市净率3.41	ROE-13.97%	每股收益-0.32
52周最高9.280	52周最低0.760	市盈率-23.19
股息0.00	股息收益率0.00	ROA-11.24%

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"歌礼制药-B","latestPrice":7.45,"timestamp":1743149290010,"preClose":7.52,"halted":0,"volume":10367000,"delay":0,"floatShares":961999999,"shares":961999999,"eps":-0.32127669389342667,"marketStatus":"已收盘","change":-0.07,"latestTime":"03-28 16:08:10","open":7.5,"high":7.72,"low":6.78,"amount":75670072,"amplitude":0.125,"askPrice":7.45,"askSize":4000,"bidPrice":7.3,"bidSize":6000,"shortable":0,"etf":0,"ttmEps":-0.32127669389342667,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1743384600000},"marketStatusCode":5,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":7.52,"openAndCloseTimeList":[[1743125400000,1743134400000],[1743138000000,1743148800000]],"volumeRatio":1.179522,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01672","defaultTab":"news","newsList":[{"id":"2518179734","title":"歌礼制药-B03月11日主力净流入124万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518179734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518179734?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:17","pubTimestamp":1741681059,"startTime":"0","endTime":"0","summary":"03月11日, 歌礼制药-B股价涨1.38%，报收7.35元，成交金额2890万元，换手率0.41%，振幅8.69%，量比0.43。歌礼制药-B今日主力资金净流入124万元，上一交易日主力净流出234万元。该股近5个交易日上涨2.08%，主力资金累计净流出582万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2865万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170647abf60d9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311170647abf60d9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1515","01477","BK1191","01672"],"gpt_icon":0},{"id":"2518731994","title":"歌礼制药-B盘中异动 股价大跌5.93%报6.820港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518731994?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:33","pubTimestamp":1741656819,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时33分，歌礼制药-B股票出现波动，股价快速下挫5.93%。截至发稿，该股报6.820港元/股，成交量9.8万股，换手率0.01%，振幅5.79%。资金方面，该股资金流入14.575万港元，流出41.807万港元。歌礼制药-B股票所在的生物技术行业中，整体跌幅为0.07%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110933399640ca46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110933399640ca46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1574","BK1161","BK1515","BK1191","01477"],"gpt_icon":0},{"id":"2517110937","title":"歌礼制药-B03月07日遭主力抛售409万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517110937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517110937?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:17","pubTimestamp":1741335427,"startTime":"0","endTime":"0","summary":"03月07日, 歌礼制药-B股价跌2.82%，报收6.90元，成交金额3108万元，换手率0.46%，振幅4.51%，量比0.36。歌礼制药-B今日主力资金净流出409万元，上一交易日主力净流出109万元。该股近5个交易日上涨4.55%，主力资金累计净流入230万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入3071万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170955a263e10f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170955a263e10f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1191","01477","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2517908031","title":"港股异动 | 歌礼制药-B(01672)涨超5% ASC30、ASC47均具备差异化设计方式 产品发展未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908031","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517908031?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:22","pubTimestamp":1741227746,"startTime":"0","endTime":"0","summary":"中信建投发布研报称，歌礼制药-B发布公告，其GLP-1R激动剂ASC30在美国Ib期临床试验取得积极成果。数据显示，前两个列队中ASC30经安慰剂组校准后分别使体重下降4.2%和6.2%，并且安全性良好。该行认为，全球减重药物市场规模蓬勃成长，众多超重或肥胖成年人群急需创新药物来改善并提高生活质量，在此基础下，公司的两款药物ASC30、ASC47均具备差异化设计方式，产品发展未来可期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","01477","BK1515","BK1574","BK1191","BK1161"],"gpt_icon":0},{"id":"2517908542","title":"歌礼制药-B盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517908542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517908542?lang=zh_cn&edition=full","pubTime":"2025-03-06 10:19","pubTimestamp":1741227599,"startTime":"0","endTime":"0","summary":"2025年03月06日早盘10时19分，歌礼制药-B股票出现波动，股价急速上涨5.14%。截至发稿，该股报7.360港元/股，成交量325.1万股，换手率0.34%，振幅5.29%。资金方面，该股资金流入953.631万港元，流出1142.22万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为2.00%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306102000a261980a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1161","BK1515","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2517496089","title":"【券商聚焦】中信建投维持歌礼制药(01672)“买入”评级 指减重、降脂药物未来可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517496089","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517496089?lang=zh_cn&edition=full","pubTime":"2025-03-05 16:16","pubTimestamp":1741162593,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研报指，歌礼制药 发布公告，其GLP-1R激动剂ASC30在美国Ib期临床试验取得积极成果。数据显示，前两个列队中ASC30经安慰剂组校准后分别使体重下降4.2%和6.2%，并且安全性良好。该行认为，全球减重药物市场规模蓬勃成长，众多超重或肥胖成年人群急需创新药物来改善并提高生活质量，在此基础下，公司的两款药物ASC30、ASC47均具备差异化设计方式，产品发展未来可期。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ZDNhNDUwNDVmY2U2MTcxMzU2NTcyMzcyOQ==.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954421","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","01477"],"gpt_icon":0},{"id":"2517932590","title":"歌礼制药-B盘中异动 早盘股价大涨5.00%报7.560港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517932590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517932590?lang=zh_cn&edition=full","pubTime":"2025-03-05 09:39","pubTimestamp":1741138743,"startTime":"0","endTime":"0","summary":"2025年03月05日早盘09时39分，歌礼制药-B股票出现波动，股价大幅拉升5.00%。截至发稿，该股报7.560港元/股，成交量41.2万股，换手率0.04%，振幅4.86%。歌礼制药-B股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，康宁杰瑞制药-B、再鼎医药、科笛-B涨幅较大，振幅较大的相关个股有康宁杰瑞制药-B、科笛-B、和誉-B，振幅分别为7.63%、7.59%、7.42%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093903a25fc2bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305093903a25fc2bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1161","BK1515","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2517937639","title":"歌礼制药-B(1672.HK)：早期临床研发取得突破 GLP1口服药物值得关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2517937639","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517937639?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:00","pubTimestamp":1741104000,"startTime":"0","endTime":"0","summary":"数据显示，前两个列队中ASC30 经安慰剂组校准后分别使体重下降4.2%和6.2%，并且安全性良好。事件公司发布公告，GLP-1R 激动剂ASC30 在美国Ib 期临床试验取得积极结果。ASC30：发布Ib 期多剂量递增研究结果，前两个队列疗效、安全性表现积极ASC30 是一款正在临床研究中的小分子GLP-1R 偏向激动剂，具有独特和差异化特性，使得同一小分子同时适用于皮下注射和口服片剂给药成为可能。安慰剂组体重下降0.1%，ASC30 组经安慰剂校准后的体重下降为6.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305100124a25fcc58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305100124a25fcc58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01477","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"2516625134","title":"歌礼制药-B03月04日主力净流出63万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2516625134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516625134?lang=zh_cn&edition=full","pubTime":"2025-03-04 17:39","pubTimestamp":1741081181,"startTime":"0","endTime":"0","summary":"03月04日, 歌礼制药-B股价跌3.23%，报收7.20元，成交金额1804万元，换手率0.26%，振幅4.84%，量比0.20。歌礼制药-B今日主力资金净流出63万元，上一交易日主力净流入765万元。该股近5个交易日上涨16.13%，主力资金累计净流入10万元；近20日主力资金累计净流入3616万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174929abe79513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304174929abe79513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01672","BK1191","01477","BK1161","BK1574","BK1515"],"gpt_icon":0},{"id":"2516573364","title":"歌礼制药-B盘中异动 快速上涨5.15%报6.940港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516573364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516573364?lang=zh_cn&edition=full","pubTime":"2025-03-03 11:09","pubTimestamp":1740971356,"startTime":"0","endTime":"0","summary":"2025年03月03日早盘11时09分，歌礼制药-B股票出现波动，股价大幅上涨5.15%。截至发稿，该股报6.940港元/股，成交量381.8万股，换手率0.40%，振幅7.73%。资金方面，该股资金流入1058.11万港元，流出1419.33万港元。歌礼制药-B股票所在的生物技术行业中，整体跌幅为0.38%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303110916abe55336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303110916abe55336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01477","BK1161","01672","BK1574"],"gpt_icon":0},{"id":"2514488363","title":"歌礼制药-B02月28日遭主力抛售2214万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514488363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514488363?lang=zh_cn&edition=full","pubTime":"2025-02-28 16:15","pubTimestamp":1740730507,"startTime":"0","endTime":"0","summary":"02月28日, 歌礼制药-B股价涨0.30%，报收6.60元，成交金额5628万元，换手率0.89%，振幅7.60%，量比0.73。歌礼制药-B今日主力资金净流出2214万元，上一交易日主力净流出279万元。该股近5个交易日上涨9.45%，主力资金累计净流出76万元；近20日主力资金累计净流入2870万元，其中净流入天数为12日。该股主力净额占比0.35%，港股市场排名2628/2648。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165319a2579bf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228165319a2579bf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01477","BK1191","BK1515","01672","BK1574","BK1161"],"gpt_icon":0},{"id":"2514681078","title":"歌礼制药-B盘中异动 早盘股价大涨5.00%报6.510港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514681078","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514681078?lang=zh_cn&edition=full","pubTime":"2025-02-26 10:04","pubTimestamp":1740535472,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘10时04分，歌礼制药-B股票出现波动，股价快速上涨5.00%。截至发稿，该股报6.510港元/股，成交量81.4万股，换手率0.08%，振幅5.00%。资金方面，该股资金流入307.03万港元，流出203.127万港元。歌礼制药-B股票所在的生物技术行业中，整体涨幅为0.90%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226100432963084cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226100432963084cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01672","BK1574","01477","BK1515","BK1191"],"gpt_icon":0},{"id":"2514908055","title":"港股生物技术股震荡走强，康希诺生物(06185.HK)涨超11%，歌礼制药(01672.HK)涨超9%，创胜集团(066","url":"https://stock-news.laohu8.com/highlight/detail?id=2514908055","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514908055?lang=zh_cn&edition=full","pubTime":"2025-02-25 10:47","pubTimestamp":1740451663,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1583","06628","01672","BK1161","BK1515","01477","07226","HSTECH","BK1191","02410","159938","02616","06185","09939","HSCEI","BK1574","YANG","01952"],"gpt_icon":0},{"id":"2514608070","title":"歌礼制药-B现涨超7% 机构指公司今年减重&降糖领域催化剂丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2514608070","media":"新浪网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514608070?lang=zh_cn&edition=full","pubTime":"2025-02-25 10:26","pubTimestamp":1740450400,"startTime":"0","endTime":"0","summary":"歌礼制药-B股价上涨7.25%，现报6.36港元，成交额4056.31万港元。海通证券指出，2025年公司减重&糖尿病领域有丰富的催化剂读出，该行看好旗下管线ASC30和ASC47的对全球竞争力，建议关注公司进展。目前公司减重&降糖领域临床阶段的管线包括口服和皮下注射剂型的小分子GLP1R 激动剂ASC30，以及脂肪靶向的小分子THRβ注射剂ASC47。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022510555798919ee3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022510555798919ee3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","01672","BK1515","BK1161","01477"],"gpt_icon":0},{"id":"2514084299","title":"【港股异动 | 歌礼制药-B(01672.HK)涨超7% 】歌礼制药-B(01672.HK)涨超7%，截至发稿，涨7.42%，报6.37港元，成交额1322.06万港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514084299","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514084299?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:59","pubTimestamp":1740448774,"startTime":"0","endTime":"0","summary":"歌礼制药-B(01672.HK)涨超7%，截至发稿，涨7.42%，报6.37港元，成交额1322.06万港元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25095948362450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01672","BK1161","BK1515","BK1574","BK1191","01477"],"gpt_icon":0},{"id":"2514084126","title":"港股异动 | 歌礼制药-B(01672)涨超7% 机构指公司今年减重&降糖领域催化剂丰富","url":"https://stock-news.laohu8.com/highlight/detail?id=2514084126","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514084126?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:51","pubTimestamp":1740448265,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B涨超7%，截至发稿，涨7.42%，报6.37港元，成交额1322.06万港元。海通证券指出，2025年公司减重&糖尿病领域有丰富的催化剂读出，该行看好旗下管线ASC30和ASC47的对全球竞争力，建议关注公司进展。目前公司减重&降糖领域临床阶段的管线包括口服和皮下注射剂型的小分子GLP1R 激动剂ASC30，以及脂肪靶向的小分子THRβ注射剂ASC47。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253805.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","BK1161","BK1574","BK1515","01672","BK1191"],"gpt_icon":0},{"id":"2514081913","title":"港股减肥药龙头歌礼制药：Ib期临床数据亮眼股价暴涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2514081913","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514081913?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:39","pubTimestamp":1740447540,"startTime":"0","endTime":"0","summary":"自2024年8月底启动转型以来，歌礼制药股价从0.76港元低位强势反弹。2025年2月20日，其宣布口服GLP-1受体激动剂ASC30的Ib期临床数据亮眼，单日上涨34.45%，收盘价6.44港元，创三年新高；2025年涨幅达96.01%，成为港股减肥药概念龙头。歌礼制药凭借MASH与肥胖症双赛道布局，或迎来“第二增长曲线”。市场分析指出，若ASC30及ASC47后续数据稳健，公司估值有望进一步释放。2月24日，歌礼制药收于5.93元/股，单日跌幅1.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225094013989185be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225094013989185be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","BK1515","01477","HSTECH","HSCEI","BK1191","01672"],"gpt_icon":1},{"id":"2514776648","title":"歌礼制药股价累涨超750%：18A企业燃动股市的关键在哪里？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514776648","media":"医药研究社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514776648?lang=zh_cn&edition=full","pubTime":"2025-02-24 20:05","pubTimestamp":1740398704,"startTime":"0","endTime":"0","summary":"01借GLP-1药物歌礼制药从风口起飞歌礼制药这轮股价涨势与行业高景气密切相关。同时我们也需关注到，歌礼制药作为港股18A第一股，其如今的业务转型、股价抬升或对整个18A板块也有激励作用。另外，截至2024年3月31日，64家已上市18A企业中，仅有4家企业的股价仍处于发行价之上。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003914a2523182&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225003914a2523182&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","01672","BK1191","01477","BK1574"],"gpt_icon":0},{"id":"2513793189","title":"歌礼制药-B盘中异动 股价大跌5.47%报5.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513793189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513793189?lang=zh_cn&edition=full","pubTime":"2025-02-24 10:02","pubTimestamp":1740362571,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘10时02分，歌礼制药-B股票出现异动，股价急速跳水5.47%。截至发稿，该股报5.700港元/股，成交量196.5万股，换手率0.20%，振幅9.95%。资金方面，该股资金流入408.183万港元，流出678.531万港元。歌礼制药-B股票所在的生物技术行业中，整体跌幅为1.39%。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224100251962dd860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224100251962dd860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1191","01672","BK1574","01477"],"gpt_icon":0},{"id":"2513253134","title":"【券商聚焦】海通证券首予歌礼制药(01672)“优于大市”评级 旗下减重&糖尿病创新药均处于全球进度前列","url":"https://stock-news.laohu8.com/highlight/detail?id=2513253134","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513253134?lang=zh_cn&edition=full","pubTime":"2025-02-21 15:31","pubTimestamp":1740123116,"startTime":"0","endTime":"0","summary":"金吾财讯 | 海通证券发研报指，2025年歌礼制药 减重&糖尿病领域有丰富的催化剂读出，该行看好旗下管线ASC30和ASC47的对全球竞争力，建议关注公司进展。该行判断围绕多靶、口服、长效、增肌减脂等需求迭代的创新药是全球减重市场的热点方向，ASC30和ASC47在展现出早期优异安全性和有效性的情况下，在各自赛道均处于全球进度前列，因此该行看好两者的全球竞争力。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZmQ4YWNjMjZmNDUwZDg4ZTlkYjEwZTY1NmI3NmEzMzkwOTI4OTA5.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953675","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","01477","01672","159992"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascletis.com","stockEarnings":[{"period":"1week","weight":-0.1861},{"period":"1month","weight":0.2129},{"period":"3month","weight":1.5666},{"period":"6month","weight":5.8991},{"period":"1year","weight":4.3333},{"period":"ytd","weight":1.4983}],"compareEarnings":[{"period":"1week","weight":-0.0265},{"period":"1month","weight":0.0237},{"period":"3month","weight":0.1736},{"period":"6month","weight":0.1428},{"period":"1year","weight":0.4384},{"period":"ytd","weight":0.1754}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"歌礼制药有限公司是一家主要从事医药产品的研发、生产、营销及销售的中国投资控股公司。该公司主要专注于病毒性疾病、非酒精性脂肪性肝炎及肿瘤领域。病毒性疾病产品管线包括利托那韦、盐酸拉维达韦、达诺瑞韦钠等。非酒精性脂肪性肝炎产品管线包括ASC40、ASC41、ASC42等。肿瘤产品管线包括ASC60、ASC61等。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.137639},{"month":2,"riseRate":0.714286,"avgChangeRate":0.094063},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.070924},{"month":4,"riseRate":0.5,"avgChangeRate":-0.033468},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.025765},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.058787},{"month":7,"riseRate":0.5,"avgChangeRate":0.006985},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.090298},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.044648},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.021896},{"month":11,"riseRate":0.857143,"avgChangeRate":0.138187},{"month":12,"riseRate":0.571429,"avgChangeRate":0.13144}],"exchange":"SEHK","name":"歌礼制药-B","nameEN":"ASCLETIS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"歌礼制药-B,01672,歌礼制药-B股票,歌礼制药-B股票老虎,歌礼制药-B股票老虎国际,歌礼制药-B行情,歌礼制药-B股票行情,歌礼制药-B股价,歌礼制药-B股市,歌礼制药-B股票价格,歌礼制药-B股票交易,歌礼制药-B股票购买,歌礼制药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"歌礼制药-B(01672)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供歌礼制药-B(01672)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}